BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia

SIMPLE SUMMARY: Chronic lymphocytic leukemia (CLL) represents the most frequent B cell malignancy in Western countries and still remains as an incurable disease. Despite recent advances in targeted therapies including ibrutinib, idelalisib or venetoclax, resistance mechanisms have been described and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sordo-Bahamonde, Christian, Lorenzo-Herrero, Seila, Gonzalez-Rodriguez, Ana P, R. Payer, Ángel, González-García, Esther, López-Soto, Alejandro, Gonzalez, Segundo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067870/
https://www.ncbi.nlm.nih.gov/pubmed/33917094
http://dx.doi.org/10.3390/cancers13081766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067870/
https://www.ncbi.nlm.nih.gov/pubmed/33917094
http://dx.doi.org/10.3390/cancers13081766

Ejemplares similares